Cipla Q4 net loss narrows to Rs 61.79 cr
New Delhi: Pharma major Cipla reported a narrowing of its consolidated net loss to Rs 61.79 crore for the fourth quarter ended March 31.
The company had posted a net loss of Rs 92.83 crore for the corresponding period of the previous fiscal, Cipla said in a BSE filing.
Consolidated total income of the company rose to Rs 3,604.79 crore for the quarter under consideration as against Rs 3,373.91 crore for the same period a year ago.
Total income of the company stood at Rs 14,858.93 crore for the fiscal ended March 31 as against Rs 13,998.31 crore for the previous fiscal year.
In another filing, the company said its board has recommended a dividend of Rs 2 per equity share for the year 2016-2017.
Shares of Cipla closed 3.12 per cent lower at Rs 504.10 per scrip on BSE today.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd